JP2024534502A - オリゴヌクレオチドのインビボ送達に使用するための2’-アルキル又は3’-アルキル修飾リボース誘導体 - Google Patents
オリゴヌクレオチドのインビボ送達に使用するための2’-アルキル又は3’-アルキル修飾リボース誘導体 Download PDFInfo
- Publication number
- JP2024534502A JP2024534502A JP2024517430A JP2024517430A JP2024534502A JP 2024534502 A JP2024534502 A JP 2024534502A JP 2024517430 A JP2024517430 A JP 2024517430A JP 2024517430 A JP2024517430 A JP 2024517430A JP 2024534502 A JP2024534502 A JP 2024534502A
- Authority
- JP
- Japan
- Prior art keywords
- scaffold
- compound
- conjugate
- optionally substituted
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163246870P | 2021-09-22 | 2021-09-22 | |
| US63/246,870 | 2021-09-22 | ||
| PCT/US2022/044377 WO2023049258A1 (en) | 2021-09-22 | 2022-09-22 | 2'-alkyl or 3'- alkyl modified ribose derivatives for use in the in-vivo delivery of oligonucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534502A true JP2024534502A (ja) | 2024-09-20 |
| JP2024534502A5 JP2024534502A5 (cg-RX-API-DMAC7.html) | 2025-09-30 |
Family
ID=84053050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517430A Pending JP2024534502A (ja) | 2021-09-22 | 2022-09-22 | オリゴヌクレオチドのインビボ送達に使用するための2’-アルキル又は3’-アルキル修飾リボース誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230241224A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4405368A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534502A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240082361A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118076619A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022352676A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3233113A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311486A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023049258A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4705312A1 (en) * | 2023-05-03 | 2026-03-11 | Sanegene Bio USA Inc. | Lipid-based conjugates for systemic, central nervous system, peripheral nervous system, and ocular delivery |
| AU2024301344A1 (en) * | 2023-07-24 | 2026-01-29 | Sanegene Bio Usa Inc. | Lipid-based enhancement agent for rna delivery and therapy |
| CN116854754B (zh) | 2023-09-01 | 2023-12-12 | 北京悦康科创医药科技股份有限公司 | 一种含有核糖环或其衍生结构的GalNAc化合物及其寡核苷酸缀合物 |
| WO2025144872A2 (en) * | 2023-12-29 | 2025-07-03 | Adarx Pharmaceuticals, Inc. | Nucleoside-derived lipids for drug delivery |
| WO2026041067A2 (en) | 2024-08-20 | 2026-02-26 | Sanegene Bio Usa Inc. | Small interfering rna targeting myostatin (mstn) and uses thereof |
| WO2026046411A1 (en) | 2024-09-02 | 2026-03-05 | Sanegene Bio Usa Inc. | Small interfering rna targeting plasminogen (plg) and uses thereof |
| WO2026092658A2 (en) | 2024-10-31 | 2026-05-07 | Sanegene Bio Usa Inc. | Small interfering rna targeting amyloid beta precursor protein (app) and uses thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014515023A (ja) * | 2011-04-13 | 2014-06-26 | メルク・シャープ・アンド・ドーム・コーポレーション | 2’−置換ヌクレオシド誘導体およびウイルス疾患の処置のためのその使用方法 |
| JP2016529230A (ja) * | 2013-07-11 | 2016-09-23 | アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. | オリゴヌクレオチド−リガンドコンジュゲートおよびそれらの調製方法 |
| CN106366146A (zh) * | 2015-07-13 | 2017-02-01 | 中科云和(北京)生物医药科技有限公司 | 2’-双烷基取代的核苷类似物及用途 |
| US20170044205A1 (en) * | 2014-04-16 | 2017-02-16 | Idenix Pharmaceuticals Llc | 3'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of hcv |
| JP2017512774A (ja) * | 2014-03-16 | 2017-05-25 | ミラゲン セラピューティクス, インコーポレイテッド | 二環式ヌクレオシドの合成 |
| JP2018500027A (ja) * | 2014-12-15 | 2018-01-11 | ダイセルナ ファーマシューティカルズ, インコーポレイテッドDicerna Pharmaceuticals, Inc. | リガンド修飾二本鎖核酸 |
| JP2018522914A (ja) * | 2015-08-13 | 2018-08-16 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Stingアゴニストとしての環状ジヌクレオチド化合物 |
| WO2021067744A1 (en) * | 2019-10-02 | 2021-04-08 | Dicerna Pharmaceuticals, Inc. | Chemical modifications of small interfering rna with minimal fluorine content |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| CA1340323C (en) | 1988-09-20 | 1999-01-19 | Arnold E. Hampel | Rna catalyst for cleaving specific rna sequences |
| GB8822492D0 (en) | 1988-09-24 | 1988-10-26 | Considine J | Apparatus for removing tumours from hollow organs of body |
| CA2039718C (en) | 1989-08-31 | 2003-02-25 | John J. Rossi | Chimeric dna-rna catalytic sequences |
| US6365730B1 (en) | 1990-06-19 | 2002-04-02 | Gene Shears Pty. Limited | DNA-Armed ribozymes and minizymes |
| US5789573A (en) | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
| AU649074B2 (en) | 1990-10-12 | 1994-05-12 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Modified ribozymes |
| DE4216134A1 (de) | 1991-06-20 | 1992-12-24 | Europ Lab Molekularbiolog | Synthetische katalytische oligonukleotidstrukturen |
| US5652094A (en) | 1992-01-31 | 1997-07-29 | University Of Montreal | Nucleozymes |
| CA2135646A1 (en) | 1992-05-11 | 1993-11-25 | Kenneth G. Draper | Method and reagent for inhibiting viral replication |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| IL108367A0 (en) | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
| US5801154A (en) | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
| US5591317A (en) | 1994-02-16 | 1997-01-07 | Pitts, Jr.; M. Michael | Electrostatic device for water treatment |
| US5631359A (en) | 1994-10-11 | 1997-05-20 | Ribozyme Pharmaceuticals, Inc. | Hairpin ribozymes |
| AU3889595A (en) | 1994-10-05 | 1996-05-02 | Amgen, Inc. | Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein |
| US5783683A (en) | 1995-01-10 | 1998-07-21 | Genta Inc. | Antisense oligonucleotides which reduce expression of the FGFRI gene |
| US5747470A (en) | 1995-06-07 | 1998-05-05 | Gen-Probe Incorporated | Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| CA2518475C (en) | 2003-03-07 | 2014-12-23 | Alnylam Pharmaceuticals, Inc. | Irna agents comprising asymmetrical modifications |
| EP2669377A3 (en) | 2003-04-17 | 2015-10-14 | Alnylam Pharmaceuticals Inc. | Modified iRNA agents |
| AU2006279906B2 (en) | 2005-08-10 | 2012-05-10 | Alnylam Pharmaceuticals, Inc. | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| EP2229186A2 (en) | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| RU2582235C2 (ru) | 2010-12-29 | 2016-04-20 | Ф.Хоффманн-Ля Рош Аг | Низкомолекулярные конъюгаты для внутриклеточной доставки нуклеиновых кислот |
| US8577565B2 (en) | 2011-12-16 | 2013-11-05 | GM Global Technology Operations LLC | Limiting branch pressure to a solenoid valve in a fluid circuit |
| TWI912633B (zh) | 2016-06-06 | 2026-01-21 | 美商愛羅海德製藥公司 | 5'-環-磷酸修飾之核苷酸 |
| MX2019002075A (es) | 2016-08-23 | 2019-07-01 | Dicerna Pharmaceuticals Inc | Composiciones que comprenden oligonucleotidos modificados reversiblemente, y sus usos. |
| WO2018045317A1 (en) | 2016-09-02 | 2018-03-08 | Dicerna Pharmaceuticals, Inc. | 4'-phosphate analogs and oligonucleotides comprising the same |
-
2022
- 2022-09-22 CA CA3233113A patent/CA3233113A1/en active Pending
- 2022-09-22 US US17/950,520 patent/US20230241224A1/en not_active Abandoned
- 2022-09-22 JP JP2024517430A patent/JP2024534502A/ja active Pending
- 2022-09-22 CN CN202280068035.1A patent/CN118076619A/zh active Pending
- 2022-09-22 EP EP22800011.3A patent/EP4405368A1/en active Pending
- 2022-09-22 WO PCT/US2022/044377 patent/WO2023049258A1/en not_active Ceased
- 2022-09-22 KR KR1020247013107A patent/KR20240082361A/ko active Pending
- 2022-09-22 IL IL311486A patent/IL311486A/en unknown
- 2022-09-22 AU AU2022352676A patent/AU2022352676A1/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014515023A (ja) * | 2011-04-13 | 2014-06-26 | メルク・シャープ・アンド・ドーム・コーポレーション | 2’−置換ヌクレオシド誘導体およびウイルス疾患の処置のためのその使用方法 |
| JP2016529230A (ja) * | 2013-07-11 | 2016-09-23 | アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. | オリゴヌクレオチド−リガンドコンジュゲートおよびそれらの調製方法 |
| JP2017512774A (ja) * | 2014-03-16 | 2017-05-25 | ミラゲン セラピューティクス, インコーポレイテッド | 二環式ヌクレオシドの合成 |
| US20170044205A1 (en) * | 2014-04-16 | 2017-02-16 | Idenix Pharmaceuticals Llc | 3'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of hcv |
| JP2018500027A (ja) * | 2014-12-15 | 2018-01-11 | ダイセルナ ファーマシューティカルズ, インコーポレイテッドDicerna Pharmaceuticals, Inc. | リガンド修飾二本鎖核酸 |
| CN106366146A (zh) * | 2015-07-13 | 2017-02-01 | 中科云和(北京)生物医药科技有限公司 | 2’-双烷基取代的核苷类似物及用途 |
| JP2018522914A (ja) * | 2015-08-13 | 2018-08-16 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Stingアゴニストとしての環状ジヌクレオチド化合物 |
| WO2021067744A1 (en) * | 2019-10-02 | 2021-04-08 | Dicerna Pharmaceuticals, Inc. | Chemical modifications of small interfering rna with minimal fluorine content |
Non-Patent Citations (1)
| Title |
|---|
| ROSENTHAL, A. ET AL.: "Branched-chain N-sugar nucleosides. 2. Nucleosides of 3-C-cyanomethyl, carboxamidomethyl, and N,N-", JOURNAL OF ORGANIC CHEMISTRY, vol. 38, no. 2, JPN6026023586, 1973, pages 198 - 201, ISSN: 0005881136 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023049258A1 (en) | 2023-03-30 |
| CN118076619A (zh) | 2024-05-24 |
| CA3233113A1 (en) | 2023-03-30 |
| KR20240082361A (ko) | 2024-06-10 |
| AU2022352676A1 (en) | 2024-03-14 |
| EP4405368A1 (en) | 2024-07-31 |
| US20230241224A1 (en) | 2023-08-03 |
| IL311486A (en) | 2024-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7842850B2 (ja) | 1’-アルキル修飾リボース誘導体及び使用方法 | |
| US20230346819A1 (en) | 5'-modified carbocyclic ribonucleotide derivatives and methods of use | |
| KR20240082361A (ko) | 올리고뉴클레오티드의 생체내 전달에 사용하기 위한 2'-알킬 또는 3'-알킬 변형된 리보스 유도체 | |
| JP2024542929A (ja) | ポリヒドロキシル化されたシクロペンタン誘導体及び使用方法 | |
| KR20260005960A (ko) | 전신, 중추 신경계, 말초 신경계, 및 안구 전달을 위한 지질 기반 접합체 | |
| JP2025541956A (ja) | Rna送達及び治療のためのヌクレオチド系増強剤 | |
| AU2024301344A1 (en) | Lipid-based enhancement agent for rna delivery and therapy | |
| WO2026102144A2 (en) | Oligonucleotide conjugates of phosphocholine lipid derivatives | |
| HK40123279A (en) | Nucleotide-based enhancement agent for rna delivery and therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250919 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250919 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260609 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260804 |